Associate Scientist / Staff Scientist (core)
Education:
Ph.D., 2000, University of the Witwatersrand, South Africa
Languages Spoken: English, Afrikaans, Swedish, Dutch
Biography
Helena’s research focuses on the pathogenesis of Mycobacterium tuberculosis, elucidating the metabolism of the pathogen under different physiological conditions, identifying and validating drug targets, understanding mechanisms of survival in non-replicating persistence and drug tolerance, in addition to high-throughput screening against BSL-3 pathogens. She is a key staff member in the Bill & Melinda Gates Foundation-supported grant under the Tuberculosis Drug Accelerator program.